Postgraduate Course: Commercial Aspects of Drug Discovery (PGBI11076)
Course Outline
School | School of Biological Sciences |
College | College of Science and Engineering |
Credit level (Normal year taken) | SCQF Level 11 (Postgraduate) |
Course type | Online Distance Learning |
Availability | Not available to visiting students |
SCQF Credits | 10 |
ECTS Credits | 5 |
Summary | **Online Distance Learning Course**
This course gives the student a general, illustrated overview over the different stages in drug discovery from the industrial perspective. A wide range of biotech and pharma business models will be presented and analysed including non-profit models for drug discovery through government agencies. The practicalities of starting up a new company in the biotech area will be explored and ideas and business plans for potential start up companies will be evaluated.
|
Course description |
Not entered
|
Entry Requirements (not applicable to Visiting Students)
Pre-requisites |
|
Co-requisites | |
Prohibited Combinations | |
Other requirements | None |
Course Delivery Information
|
Academic year 2017/18, Not available to visiting students (SS1)
|
Quota: None |
Course Start |
Semester 2 |
Course Start Date |
15/01/2018 |
Timetable |
Timetable |
Learning and Teaching activities (Further Info) |
Total Hours:
100
(
Online Activities 20,
Programme Level Learning and Teaching Hours 2,
Directed Learning and Independent Learning Hours
78 )
|
Assessment (Further Info) |
Written Exam
0 %,
Coursework
100 %,
Practical Exam
0 %
|
Additional Information (Assessment) |
50 % group assessment (including maximum 20% variation for Peer Assessment of contribution)
50 % electronic portfolio comprising learning log and contribution to Skills Profile
|
Feedback |
Not entered |
No Exam Information |
Learning Outcomes
On completion of this course, the student will be able to:
- At the end of this course a student should have: Knowledge of the cost structure of a traditional pharmaceutical corporation.
- An understanding of the development pipeline of a major pharmaceutical corporation
- Knowledge of the regulatory hurdles that must be passed to bring a new compound to market and the costs associated with these hurdles
- An ability to put together and evaluate a business plan for a start-up biotech company.
|
Additional Information
Graduate Attributes and Skills |
Not entered |
Keywords | eCADD |
Contacts
Course organiser | Dr Douglas Houston
Tel: (0131 6)50 7358
Email: |
Course secretary | Mrs Claire Black
Tel: (0131 6)50 8637
Email: |
|
|